Department of Thoracic Surgery and Oncology, The Second Department of Thoracic Surgery, Cancer Center, First Affiliated Hospital of Xi'an Jiaotong University , Xi'an, Shaanxi, P.R.China.
Department of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an, Shaanxi, P.R.China.
Cell Cycle. 2020 Dec;19(23):3249-3259. doi: 10.1080/15384101.2020.1838791. Epub 2020 Nov 9.
Matrine is one of the major alkaloids extracted from Sophora flavescens Ait of the traditional Chinese medicine, was the main chemical ingredient of compounds of Kushen injection. The Matrine is considered as a promising therapeutic agent for curing nonsmall cell lung cancer (NSCLC), used either alone or combined with chemotherapeutic agents. In the present study, we focused on the possible roles of Matrine exerted on the self-renewal ability of stem-like cells of the NSCLC group, as well as the cytotoxicity of chemotherapeutic agents, in vitro and in vivo. Here we reported that Matrine inhibits cancer stem-like cell (CSC) properties through upregulation of Let-7b and suppression of the Wnt pathway. Overexpression of Let-7b suppressed the ability of tumorsphere formation, decreased Wnt pathway activation through inhibiting its transcriptional activity in lung CSCs. Further studies revealed that Let-7b directly targeted CCND1 and decreased its expression, whereas Matrine increased Let-7b levels and followed by inactivation of the CCND1/Wnt signaling pathway and inhibition of EMT, which was characterized by loss of epithelial markers and acquisition of a mesenchymal phenotype in lung CSCs. What is more, we found that Matrine increased Let-7b level in an endoribonuclease DICER1-dependent manner. And xenografts in nude mice evidenced that Matrine increased the sensitivity of lung CSCs to 5-FU and inhibited the accumulation of CCND1 in tumor tissues induced by 5-FU. Taken together, these data illustrate the role of Let-7b in regulating lung CSCs traits and DICER1/let-7/CCND1 axis in Matrine or in combination with 5-FU intervention of lung CSCs' expansion, helping to fulfill the anti-cancer action of Matrine.
苦参碱是从苦参的传统中药中提取的主要生物碱之一,是苦参注射液化合物的主要化学成分。苦参碱被认为是治疗非小细胞肺癌(NSCLC)的有前途的治疗剂,可单独使用或与化疗药物联合使用。在本研究中,我们专注于苦参碱在体外和体内对 NSCLC 组干细胞样细胞的自我更新能力以及化疗药物的细胞毒性的可能作用。在这里,我们报道苦参碱通过上调 Let-7b 并抑制 Wnt 通路来抑制癌症干细胞样细胞(CSC)特性。Let-7b 的过表达抑制肿瘤球形成能力,通过抑制其在肺 CSCs 中的转录活性,降低 Wnt 通路的激活。进一步的研究表明,Let-7b 直接靶向 CCND1 并降低其表达,而苦参碱增加 Let-7b 水平并随后失活 CCND1/Wnt 信号通路并抑制 EMT,其特征是上皮标志物的丧失和获得肺 CSCs 的间充质表型。更重要的是,我们发现苦参碱以依赖内切核酸酶 DICER1 的方式增加 Let-7b 水平。裸鼠异种移植证实,苦参碱增加了肺 CSCs 对 5-FU 的敏感性,并抑制了 5-FU 诱导的肿瘤组织中 CCND1 的积累。总之,这些数据说明了 Let-7b 在调节肺 CSCs 特性和 DICER1/let-7/CCND1 轴中的作用,以及苦参碱或与 5-FU 联合干预肺 CSCs 扩增在发挥抗癌作用中的作用。